Related Experiment Video
Updated: Jul 18, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process]
1Department of Hemostatic Physiology, Hunan Medical University, Changsha 410078, China.
Objective:
To establish a screening test that can reflect two stages of coagulation process.
Methods:
With FXII a being blocked, the effects of various dilution of thromboplastin on clotting time were observed. FX a activity was determined by chromogenic assay.
Results:
(1) At high concentration of thromboplastin, FXII a-inhibited diluted thromboplastin time (FXII ai DTT) of pooled normal plasma and FXI deficient plasma was very similar, but at low concentration, FXII ai DTT was in order of FVIII and FIX deficient plasma > FXI deficient plasma > pooled normal plasma. (2) FXI consumption by immunologic method induced FXII ai DTT of pooled normal plasma prolonged, and addition of FXI to FXI deficient plasma shortened FXII ai DTT. (3) Alpha-thrombin blocked by hirudin at different time (10 - 80 seconds) resulted in decreased FXa generation, and the earlier the block, the more the decrease. Under the same condition, the amount of FXa generation was in order of platelet-rich plasma > platelet-poor plasma > FXI deficient plasma.
Conclusion:
(1) Our data support the two-stage hypothesis and confirm the important role of FXI in the amplification stage. (2) FXII ai DTT as a screening test for coagulation process may be practicable.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care